Fluorescent chiral selective receptors are set to revolutionize the diagnosis and treatment of diabetes. Researchers have developed a fluorescent chiral receptor that can detect glucose in its enantiomeric form, which has never been achieved before. This technology could lead to advances in diabetes diagnosis and treatment, as it could enable a more precise measurement of glucose levels in the body. The new fluorescent chiral receptor works by binding to the glucose molecules, thus enabling its detection. This technology could be used to quickly and accurately detect glucose levels in a person’s body. This could help medical professionals monitor glucose levels more closely, and make better decisions about diabetes treatment.

Read Full Article Here

source: Phys.org